Thursday, May 1st, 2025

How to Exercise Your Rights as a Non-Assenting Shareholder in YTL Cement’s Acquisition of NSL Ltd








Singapore Shareholders: Exercise Your Rights Before It’s Too Late!

Singapore Shareholders: Exercise Your Rights Before It’s Too Late!

In a significant move that could impact the stock value of NSL Ltd., YTL Cement Berhad has launched a mandatory unconditional cash offer. Non-Assenting Shareholders are urged to pay attention to the critical details outlined in the Form of Exercise and Transfer (FET) and the accompanying Notification Letter.

Key Points of the Offer

The offer presents shareholders with the right to exercise the S215(3) provision under the Companies Act 1967. This right allows non-assenting shareholders to require YTL Cement to acquire their shares at S\$0.75 in cash per Exercise Share. Shareholders must act before the deadline of 5.30 p.m. Singapore time on 5 March 2025, to avail of this offer.

Important Considerations

Overseas shareholders should note that the exercise of the S215(3) right may be influenced by local laws in their respective jurisdictions. It is crucial that they understand these implications as outlined in the Notification Letter.

Instructions for Shareholders

Shareholders wishing to exercise their rights must complete the FET accurately. This includes specifying the number of shares and ensuring all necessary documents accompany the form. Notably, any exercise of the S215(3) right is irrevocable, emphasizing the need for careful consideration before submission.

Execution and Submission

For individuals, the form must be signed in the presence of a witness, while corporations must execute it under their common seal. The completed FET and accompanying documents can be submitted by hand or post to the designated address. Incomplete or incorrectly executed forms risk being rejected.

Potential Impact on Share Price

This offer and the conditions associated with the exercise of the S215(3) right could influence NSL Ltd.’s share price. Shareholders should consider the cash offer price of S\$0.75 per share in their investment decisions.

Conclusion

Shareholders are encouraged to consult with financial advisors to fully understand the implications of the offer and to make informed decisions regarding their shareholdings in NSL Ltd.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. Shareholders are advised to seek professional consultation before making any investment decisions.




View NSL Historical chart here



AEM’s AI-Driven Test Solutions Poised to Dominate $8B Semiconductor Market

AEM Holdings Increases 2H2024 Guidance Amid New Product Commercialization and Strategic Expansion AEM Holdings Increases 2H2024 Guidance Amid New Product Commercialization and Strategic Expansion AEM Holdings Ltd., a leader in application-specific test and handling...

Singapore’s Proton Therapy Pioneer Faces Challenges: SIAMH Addresses Auditor Concerns and Charts Path to Profitability

Proton Therapy Struggles: SIAMH Faces Financial Hurdles and Auditor Concerns Proton Therapy Struggles: SIAMH Faces Financial Hurdles and Auditor Concerns Singapore Institute of Advanced Medicine Holdings Ltd. (SIAMH), listed on the Catalist of the...

Emperador Inc. Shares on SGX: Essential Guide to Stock Transaction Tax Collection and Payment

Emperador Inc. Shareholders Alert: Stock Transaction Tax Rules Could Impact Trading Emperador Inc. Shareholders Alert: Stock Transaction Tax Rules Could Impact Trading Shareholders of Emperador Inc. (“EMI”), whose shares are traded on the Singapore...